{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Use of GLP-1 Receptor Agonists in Patients with T2DM and Chronic Kidney Disease
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Purpose of Activity
To provide information about how the differences between GLP-1 receptor agonists relate to patients with T2DM and CKD.Learning Objectives
After completing this continuing education activity you will be able to:
- Discuss the physiologic relationship between diabetes mellitus, CKD, CVD, and GLP-1 RAs.
- Recognize desired and untoward effects and contraindications of GLP-1 RAs.
- Determine proper dosing of GLP-1 RAs.
Disclosures
The author, faculty, and staff have no relevant financial relationship with any ineligible organizations regarding this educational activity.
Price:
$17.95
Credits:
- ACPE 1.5 CH
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. UAN 0431-0000-22-028-H04-P
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Pharmacist
Test Code: NP0319BPH
Published: Mar 2019
Expires: 9/13/2025
Sources:
Allied Health Collection
Required Passing Score: 14/18 (77%)